![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Identification of a baseline algorithm to select chronic hepatitis B patients for therapy with peginterferon alfa-2a [40KD] (PEGASYS)
|
|
|
Reported by Jules Levin
APASL March 2010
Teerha Piratvisuth1, Uri Lopatin2, Philip McCloud3
1. NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Thailand; 2. pRED, Roche Palo Alto, USA;
3. Biostatistics, Roche, Dee Why, Australia
![](../images/033110/033110-2/image002.gif)
![](../images/033110/033110-2/image004.gif)
![](../images/033110/033110-2/image006.gif)
![](../images/033110/033110-2/image008.gif)
![](../images/033110/033110-2/image010.gif)
1. Fried et al. Hepatology 2008
![](../images/033110/033110-2/image012.gif)
![](../images/033110/033110-2/image014.gif)
![](../images/033110/033110-2/image016.gif)
![](../images/033110/033110-2/image018.gif)
![](../images/033110/033110-2/image020.gif)
![](../images/033110/033110-2/image022.gif)
![](../images/033110/033110-2/image024.gif)
![](../images/033110/033110-2/image026.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|